EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs






Journal of the American Veterinary Medical Association 199(8): 1043-1046

Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs

Sixty dogs with chronic keratoconjunctivitis sicca were treated by topical administration of 2% cyclosporine twice daily. Causes and duration of keratoconjunctivitis varied. Tear production improved in 75 of 100 eyes, and corneal pigmentation decreased in 45 of 67 eyes. Six factors were evaluated to determine their influence on treatment outcome. The only significant variable was the initial Schirmer tear test value. Side effects were few. Evidence of burning in response to application of cyclosporine resolved with change in the formulation of the topical solution.

(PDF 0-2 workdays service: $29.90)

Accession: 002263757

PMID: 1748607



Related references

Topical administration of petrolatum based cyclosporine for treatment of keratoconjunctivitis sicca in dogs. Journal of Veterinary Clinics 19(2): 260-263, 2002

Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca. American Journal of Veterinary Research 63(5): 688-694, 2002

Keratoconjunctivitis sicca in dogs: Treatment with topical cyclosporine. Veterinary medicine reportng 2(2): 115-127, 1990

Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs. Journal of the American Veterinary Medical Association 199(8): 1039-1042, 1991

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine. Veterinary Immunology and Immunopathology 49(3): 199-208, 1995

Clinical evaluation of 1 percent cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs. Journal of the American Veterinary Medical Association 199(8): 1039-1042, 1991

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2 percent cyclosporine. Veterinary Immunology & Immunopathology 49(3): 199-208, 1995

Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca. American Journal of Veterinary Research 56(7): 880-884, 1995

Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine. Advances in Experimental Medicine and Biology 438: 997-1000, 1998

Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine. Biotechnic & Histochemistry 90(3): 223-230, 2015